[go: up one dir, main page]

MA34887B1 - Utilisation de (5s,8s)-3-(4'-chloro-3'-fluoro-4-méthylbiphényl-3-yl)-4-hydroxy- 8-méthoxy-1-azaspiro[4.5]décane-3-en-2-one (composé a) à des fins thérapeutiques - Google Patents

Utilisation de (5s,8s)-3-(4'-chloro-3'-fluoro-4-méthylbiphényl-3-yl)-4-hydroxy- 8-méthoxy-1-azaspiro[4.5]décane-3-en-2-one (composé a) à des fins thérapeutiques

Info

Publication number
MA34887B1
MA34887B1 MA36152A MA36152A MA34887B1 MA 34887 B1 MA34887 B1 MA 34887B1 MA 36152 A MA36152 A MA 36152A MA 36152 A MA36152 A MA 36152A MA 34887 B1 MA34887 B1 MA 34887B1
Authority
MA
Morocco
Prior art keywords
methylbiphenyl
azaspiro
decane
fluoro
chloro
Prior art date
Application number
MA36152A
Other languages
English (en)
Inventor
Ningshu Liu
Kai Thede
Philip Lienau
Arne Scholz
Christoph-Stephan Hilger
Ulf Bömer
Maher Najjar
Knut Eis
Reiner Fischer
Wahed Ahmed Moradi
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102011011040A external-priority patent/DE102011011040A1/de
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of MA34887B1 publication Critical patent/MA34887B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/54—Spiro-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

L'invention concerne l'utilisation de (5S,8S)-3-(4'-chloro-3'-fluoro-4-méthylbiphényl-3-yl)-4-hydroxy- 8-méthoxy-1-azaspiro[4.5]décane-3-en-2-one à des fins thérapeutiques, et des agents pharmaceutiques et leur utilisation en thérapie, en particulier pour la prophylaxie et la thérapie de maladies tumorales.
MA36152A 2011-02-06 2012-02-03 Utilisation de (5s,8s)-3-(4'-chloro-3'-fluoro-4-méthylbiphényl-3-yl)-4-hydroxy- 8-méthoxy-1-azaspiro[4.5]décane-3-en-2-one (composé a) à des fins thérapeutiques MA34887B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KW1411 2011-02-06
DE102011011040A DE102011011040A1 (de) 2011-02-08 2011-02-08 (5s,8s)-3-(4'-Chlor-3'-fluor-4-methylbiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-on (Verbindung A) zur Therapie
PCT/EP2012/051895 WO2012104428A1 (fr) 2011-02-06 2012-02-03 Utilisation de (5s,8s)-3-(4'-chloro-3'-fluoro-4-méthylbiphényl-3-yl)-4-hydroxy- 8-méthoxy-1-azaspiro[4.5]décane-3-en-2-one (composé a) à des fins thérapeutiques

Publications (1)

Publication Number Publication Date
MA34887B1 true MA34887B1 (fr) 2014-02-01

Family

ID=49485835

Family Applications (1)

Application Number Title Priority Date Filing Date
MA36152A MA34887B1 (fr) 2011-02-06 2012-02-03 Utilisation de (5s,8s)-3-(4'-chloro-3'-fluoro-4-méthylbiphényl-3-yl)-4-hydroxy- 8-méthoxy-1-azaspiro[4.5]décane-3-en-2-one (composé a) à des fins thérapeutiques

Country Status (19)

Country Link
US (1) US9212140B2 (fr)
EP (1) EP2670408A1 (fr)
JP (1) JP2014504624A (fr)
KR (1) KR20140053844A (fr)
CN (1) CN103533932A (fr)
AP (1) AP2013007057A0 (fr)
AR (1) AR085146A1 (fr)
AU (1) AU2012213344A1 (fr)
BR (1) BR112013020015A2 (fr)
CA (1) CA2826515A1 (fr)
CL (1) CL2013002247A1 (fr)
EA (1) EA201391084A1 (fr)
IL (1) IL227804A0 (fr)
MA (1) MA34887B1 (fr)
MX (1) MX2013009065A (fr)
PH (1) PH12013501638A1 (fr)
TN (1) TN2013000336A1 (fr)
TW (1) TW201240659A (fr)
WO (1) WO2012104428A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2016002479A (es) 2013-09-12 2016-05-31 Pfizer Uso de inhibidores de acetil-coa carboxilasa para tratar acne vulgaris.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2072695A (en) * 1994-04-05 1995-10-23 Bayer Aktiengesellschaft Alkoxy-alkyl-substituted 1-h-3-aryl-pyrrolidine-2,4-diones used as herbicides and pesticides
DE19813354A1 (de) * 1998-03-26 1999-09-30 Bayer Ag Arylphenylsubstituierte cyclische Ketoenole
DE10201239A1 (de) * 2002-01-15 2003-07-24 Bayer Cropscience Ag Fungizide biphenylsubstituierte cyclische Ketoenole
DE102006057037A1 (de) * 2006-12-04 2008-06-05 Bayer Cropscience Ag cis-Alkoxyspirocyclische biphenylsubstituierte Tetramsäure-Derivate
TW201014822A (en) * 2008-07-09 2010-04-16 Sanofi Aventis Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
DE102010008644A1 (de) * 2010-02-15 2011-08-18 Bayer Schering Pharma Aktiengesellschaft, 13353 Zyklische Ketoenole zur Therapie

Also Published As

Publication number Publication date
US9212140B2 (en) 2015-12-15
CN103533932A (zh) 2014-01-22
CL2013002247A1 (es) 2014-01-03
IL227804A0 (en) 2013-09-30
EA201391084A1 (ru) 2014-02-28
EP2670408A1 (fr) 2013-12-11
BR112013020015A2 (pt) 2017-03-21
MX2013009065A (es) 2013-10-01
TN2013000336A1 (en) 2015-01-20
WO2012104428A1 (fr) 2012-08-09
JP2014504624A (ja) 2014-02-24
AU2012213344A1 (en) 2013-08-22
AP2013007057A0 (en) 2013-08-31
TW201240659A (en) 2012-10-16
CA2826515A1 (fr) 2012-08-09
US20140031407A1 (en) 2014-01-30
PH12013501638A1 (en) 2013-09-16
AR085146A1 (es) 2013-09-11
KR20140053844A (ko) 2014-05-08

Similar Documents

Publication Publication Date Title
UA117451C2 (uk) Терапевтично активні сполуки і способи їх застосування
PH12015502628B1 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of disease
WO2015054619A8 (fr) Utilisation d'un inhibiteur de pcsk9 pour traiter l'hyperlipidémie
EA201692271A1 (ru) Терапевтически активные соединения и способы их применения
MX2015016344A (es) Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades.
MX345928B (es) Composiciones terapeuticamente activas y metodos de uso de las mismas.
MX2015008957A (es) Fluoro-[1,3]oxazinas como inhibidores de beta-secretasa 1 (bace1).
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
IN2012DN06720A (fr)
MA35716B1 (fr) Formulations pharmaceutiques
WO2015123423A3 (fr) Méthodes de traitement de patients atteints d'hypercholestérolémie non correctement maîtrisée par une thérapie à la statine à dose modérée
PH12015502365A1 (en) Bace1 inhibitors
EA201400165A1 (ru) Частицы на основе полиакрилата, которые содержат активное соединение
PH12014502541A1 (en) 5-amino [1,4] thiazines as bace 1 inhibitors
PH12014500250A1 (en) Substituted 3-(biphenyl-3-yl)-4 -hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one
PH12015501793A1 (en) Bicyclic compounds
EA201501164A1 (ru) Твердая фармацевтическая лекарственная форма
EA201691058A1 (ru) Производные пирролопирролона и их применение для лечения заболеваний
MX2014014066A (es) Compuestos de cromano.
TR201908151T4 (tr) İzoindolin türevleri.
SG10201809506TA (en) Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions
MA34887B1 (fr) Utilisation de (5s,8s)-3-(4'-chloro-3'-fluoro-4-méthylbiphényl-3-yl)-4-hydroxy- 8-méthoxy-1-azaspiro[4.5]décane-3-en-2-one (composé a) à des fins thérapeutiques
MX2012002952A (es) Agente terapeutico para el dolor cronico.
NZ623275A (en) Treatment of ocular disease
MX2013006980A (es) Composicion con un inhibidor de la bomba de protones y un antagonista h2.